Brainsway (BWAY) director exercises 27,500 options, uses 9,520 shares for tax
Rhea-AI Filing Summary
Brainsway Ltd. director Mitrany Rayten Michal Ety exercised stock options for 27,500 Ordinary Shares and settled related taxes with shares. On May 19–20, 2026, 27,500 options with an exercise price of NIS 15.26 per share were exercised, while 9,520 Ordinary Shares were retained by the company at NIS 44.36 and NIS 43.92 per share to cover the exercise price and tax liabilities.
Following these transactions, the director holds 30,480 Ordinary Shares directly, a figure that includes unvested RSUs for 6,250 shares that vest quarterly until March 5, 2028. The Ordinary Shares may also be represented by American Depositary Shares, each currently equal to one Ordinary Share. The filing reflects routine compensation-related activity rather than open‑market buying or selling.
Positive
- None.
Negative
- None.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Stock Options (right to buy) | 17,500 | $0.00 | -- |
| Exercise | Ordinary Shares | 17,500 | $0.00 | -- |
| Tax Withholding | Ordinary Shares | 6,080 | $0.00 | -- |
| Exercise | Stock Options (right to buy) | 10,000 | $0.00 | -- |
| Exercise | Ordinary Shares | 10,000 | $0.00 | -- |
| Tax Withholding | Ordinary Shares | 3,440 | $0.00 | -- |
Footnotes (1)
- The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. The exercise price is NIS 15.26 per share. This figure includes ordinary shares and unvested restricted stock units ("RSUs") to receive 6,250 ordinary shares that vest quarterly until March 5, 2028, with each RSU representing a contingent right to receive one ordinary share. These shares were retained by the Company at a price of NIS 44.36 per share in payment of the exercise price of the employee stock options exercised by the Reporting Person. These shares were retained by the Company at a price of NIS 43.92 per share in payment of the exercise price of the employee stock options exercised by the Reporting Person. Stock options were granted on January 13, 2020, and were fully vested by November 28, 2023.